Zhende Medical Co (SHSE:603301) ROCE %: 6.93% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603301 Zhende Medical Co Ltd SHSE:603301
53 GF Score
Price ¥81.24
GF Value ¥26.63
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Zhende Medical Co ROCE %?

Zhende Medical Co SHSE:603301 -3.46% 53 ROCE % is 6.93% as of Jun. 2026. GuruFocus rates SHSE:603301 with a GF Score™ of 53/100 and a GF Value™ of ¥26.63 (Significantly Overvalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhende Medical Co's annualized ROCE % for the quarter that ended in Jun. 2026 was 6.93%.

Zhende Medical Co  (SHSE:603301) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhende Medical Co ROCE % Related Terms

Zhende Medical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Zhende Medical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhende Medical Co ROCE % Chart

Zhende Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.76 14.92 3.97 8.06 5.48

Zhende Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 6.27 4.98 4.46 6.93
SHSE:603301
53GF Score
Zhende Medical Co Ltd SHSE:603301
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhende Medical Co ROCE % Calculation

Zhende Medical Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=356.317/( ( (7576.854 - 1160.034) + (8400.888 - 1808.155) )/ 2 )
=356.317/( (6416.82+6592.733)/ 2 )
=356.317/6504.7765
=5.48 %

Zhende Medical Co's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=458.572/( ( (8364.791 - 1716.841) + (8341.544 - 1751.002) )/ 2 )
=458.572/( ( 6647.95 + 6590.542 )/ 2 )
=458.572/6619.246
=6.93 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.93% mean?
Zhende Medical Co (SHSE:603301) has a ROCE % of 6.93% as of Jun. 2026.
Is Zhende Medical Co's ROCE % too high?
Zhende Medical Co's current ROCE % is 6.93%. The Medical Devices & Instruments industry median ROCE % is 2.97. Zhende Medical Co's value of 6.93% is 133.3% above this industry median. Overall, Zhende Medical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhende Medical Co's ROCE % compare to ISRG and BDX?
Zhende Medical Co's ROCE % of 6.93% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.97. Zhende Medical Co's value of 6.93% is 133.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.97, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhende Medical Co's current ROCE % of 6.93% is 133.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhende Medical Co's current ROCE % is 6.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhende Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhende Medical Co (SHSE:603301) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥26.63, compared to a current price of ¥81.24 — trading 205.1% above its estimated fair value. The current ROCE % is 6.93% and 133.3% above the Medical Devices & Instruments industry median of 2.97. Zhende Medical Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zhende Medical Co (SHSE:603301), the current ROCE % is 6.93% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhende Medical Co (SHSE:603301) Overvalued in 2026?

Based on GuruFocus' analysis, Zhende Medical Co stock appears to be overvalued. The current stock price of ¥81.24 is trading 205.1% above its estimated GF Value™ of ¥26.63. GuruFocus considers Zhende Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603301:

  • ROCE %: 6.93%
  • GF Value™: ¥26.63 vs. price of ¥81.24 (205.1% above fair value)
  • GF Score™: 53/100 with 4 warning signs
  • Industry Position: 133.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHSE:603301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhende Medical Co Business Description

Address No. 55 Xiangji Road, Gaobu Street, Yuecheng District, Zhejiang Province, Shaoxing City, CHN, 312035
Zhende Medical Co Ltd operates as a supplier of medical care and protection in China. The company is engaged in the production and sales of medical dressings. Its product categories are basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, Isolation protection, and personal protection.
53GF Score

Get the complete analysis for SHSE:603301

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥81.24
Price
¥26.63
GF Value